{
    "symbol": "IRMD",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-05 22:03:04",
    "content": " As we reported earlier this morning, revenue in the third quarter of 2022 was 13.4 million, an increase of 23% compared to third quarter of 2021. The average selling price of our MRI compatible IV infusion pump system during the third quarter of 2022 was approximately $30,000 compared to approximately $33,000 for the third quarter of 2021. The average selling price of our MRI compatible patient vital signs monitoring system during the third quarter of 2022 with approximately $46,000 compared to approximately $41,000 for the same period in 2021. Operating expenses were $6.4 million or 47.8% of revenue, compared to $5.3 million or 48.6% of revenue for the third quarter of 2021. We recognized the tax expense during the third quarter of 2022 of approximately $810,000 resulting in an effective tax rate of 19.1% compared to a tax expense of approximately $518,000 in the 2021 quarter."
}